Benzinga's Top #PreMarket Gainers

By: via Benzinga
Intra-Cellular Therapies Inc (NASDAQ: ITCI) shares rose 45.54 percent to $38.00 in pre-market trading following the announcement of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.